Evidence map›Paper›PMID 31441941›Full record

ArticleJAMA network open2019

Association of Restless Legs Syndrome With Risk of Suicide and Self-harm.

Sheng Zhuang, Muzi Na, John W Winkelman, Djibril Ba, Chun-Feng Liu, Guodong Liu, Xiang Gao

Open access · goldAbstract read
In one paragraph

Article in JAMA network open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 68 citations in OpenAlex.

  1. Trial
  2. Noninvasive neuromodulation reduces symptoms of restless legs syndrome.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2021
    Trial
  3. Low 5HTJournal of neurochemistry · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Opioids and restless legs syndrome: a double-edged sword.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2023
    Article
  13. Article
  14. Review
  15. Genetic evidence for a potential causal relationship between insomnia symptoms and suicidal behavior: a Mendelian randomization study.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Commented on by
    2019
5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Sheng ZhuangDepartment of Neurology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Muzi NaDepartment of Nutritional Sciences, Pennsylvania State University, State College, University Park.
John W WinkelmanDepartment of Psychiatry, Massachusetts General Hospital, Boston.
Djibril BaDepartment of Public Health Sciences, Pennsylvania State University College of Medicine, Hershey.
Chun-Feng LiuDepartment of Neurology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Guodong LiuDepartment of Public Health Sciences, Pennsylvania State University College of Medicine, Hershey.
Xiang GaoDepartment of Nutritional Sciences, Pennsylvania State University, State College, University Park.
Pennsylvania State University · USMassachusetts General Hospital · USSecond Affiliated Hospital of Soochow University · CNSoochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Restless legs syndrome (RLS) is a common neurologic disorder that has been previously found to be associated with higher odds of suicidal ideation. In the context of the increasing suicide rate in the United States, the evidence regarding the association between RLS and the risk of suicide and self-harm is limited. Objective: To investigate the association between RLS and risk of suicide and self-harm. Design, Setting, and Participants: This cohort study was performed using Truven Health MarketScan national claims data from 2006 to 2014; the baseline data were from 2006 to 2008, and the follow-up data covered 6 years (January 1, 2009, to December 31, 2014). Included were 24 179 nonpregnant participants with RLS and 145 194 age- and sex-matched participants without RLS at baseline (2006-2008), who were free of suicide, self-harm, cardiovascular disease, or cancer at study baseline. Data analysis was performed from February 1, 2018, to January 1, 2019. Exposure: Diagnosis of RLS, as identified by the International Classification of Diseases, Ninth Revision code. Main Outcomes and Measures: Incident suicide and self-harm event, identified by the International Classification of Diseases, Ninth Revision diagnosis code. Results: Among 169 373 participants in the current analysis, the mean (SD) age was 49.4 (9.1) years; 53 426 (31.5%) participants were men. During a mean (SD) follow-up duration of 5.2 (2.2) years, 119 incident suicide and self-harm cases were identified. Individuals with RLS had a higher risk of suicide or self-harm compared with those without RLS (adjusted hazard ratio, 2.66; 95% CI, 1.70-4.15), after adjusting for lifestyle factors (eg, alcohol and obesity), presence of chronic diseases (eg, depression, insomnia, diabetes, chronic kidney disease, peripheral neuropathy, iron-deficiency anemia, and Parkinson disease), and use of medications. Excluding those with depression, insomnia, obstructive sleep apnea, and other common chronic conditions, the significant association between RLS and suicide or self-harm persisted (adjusted hazard ratio, 4.14; 95% CI, 2.17-7.92). Conclusions and Relevance: Restless legs syndrome was associated with a high risk of suicide and self-harm, and the risk was independent of most identified diseases and conditions.

Indexed as

AdultCardiovascular DiseasesCase-Control StudiesChronic DiseaseFemaleFollow-Up StudiesHumansLife StyleMaleMiddle AgedOutcome Assessment, Health CarePrevalenceRestless Legs SyndromeRisk AssessmentSelf-Injurious BehaviorSuicidal Ideation

Identifiers

PMID31441941
PMCPMC6714009
OpenAlexW2969379798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.